Welcome: Guest | Register | Login |

Ophidion Inc

Profile last edited on: 1/19/18
2275 East Foothill Boulevard
Pasadena, CA 91107
  (646) 303-0621
  andreas.walz@ophidionbio.com
  www.ophidionbio.com
Business Identifier: Developing a new class of safe and effective drugs to target the most important receptors in the central nervous system. The activity of this target is implicated in cognitive processes, anxiety and depression, pain, as well as many other important medical indications.
Public Profile:
Ophidion, Inc., a private biotechnology company is developing a new class of safe and effective drugs targeting some of the most important receptors in the central nervous system. The activity of this target is implicated in cognitive processes (important for the alleviation of symptoms of, as examples, Schizophrenia, ADHD, and Parkinsons and Alzheimers disease), anxiety and depression, pain, as well as many other important medical indications. Ophidions approach is an improvement over drugs that continuously activate or suppress these receptors everywhere, thereby causing significant side effects, and that over time cause receptor down-regulation and/or desensitization, and hence loss of efficacy. Ophidion will initially focus on the development of cognitive enhancement drugs, based on the unmet need for more effective cognitive treatment not only for Alzheimers disease patients, but also for the treatment of patients suffering from other dementias, including age-associated memory impairment, mild cognitive impairment, Parkinsons disease, and vascular dementia; from impaired cognitive abilities in other CNS disorders, such as depression, ADHD, schizophrenia, and autism, and vascular disorders, including hypertension, diabetes, and stroke; and for post-surgical and chemotherapy patients. Safer and more effective medication for these population groups would expand the market for cognitive drugs dramatically. Furthermore, the aging population represents additional, enormous growth potential.

 Synopsis: Awardee Business Condition
Year Founded First SBIR Year Date of Last Award
Employee Range VC funded? IP Holdings
Revenue Range Private/Public Exchange/Symbol :

Smart Office Options

SBIR firms in the news



Contact information

Innovation Development Institute, LLC

   45 Beach Bluff Avenue, Suite 300
     Swampscott,  MA 01907-1542

  Tel:  (781) 595-2920

  support@inknowvation.com